RTW Investments, a $6.5 billion hedge fund specializing in the life sciences, is being investigated by the Securities and Exchange Commission.
Trade allocations by portfolio managers are coming under increased scrutiny as federal prosecutors charge a high-profile bond fund manager.
The Federal Reserve’s interest rate easing cycle appears to be nearing a pause rather than a continuation, according to Deutsche Bank.
For wealth advisors, navigating the ever-shifting dynamics of fund performance requires clarity and consistency.